Advertisement
UK markets closed
  • FTSE 100

    7,952.62
    +20.64 (+0.26%)
     
  • FTSE 250

    19,884.73
    +74.07 (+0.37%)
     
  • AIM

    743.26
    +1.15 (+0.15%)
     
  • GBP/EUR

    1.1712
    +0.0019 (+0.16%)
     
  • GBP/USD

    1.2622
    +0.0000 (+0.00%)
     
  • Bitcoin GBP

    55,810.43
    +168.99 (+0.30%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • S&P 500

    5,254.35
    +5.86 (+0.11%)
     
  • DOW

    39,807.37
    +47.29 (+0.12%)
     
  • CRUDE OIL

    83.11
    -0.06 (-0.07%)
     
  • GOLD FUTURES

    2,254.80
    +16.40 (+0.73%)
     
  • NIKKEI 225

    40,369.44
    +201.37 (+0.50%)
     
  • HANG SENG

    16,541.42
    +148.58 (+0.91%)
     
  • DAX

    18,492.49
    +15.40 (+0.08%)
     
  • CAC 40

    8,205.81
    +1.00 (+0.01%)
     

Worldwide Pharmaceutical Intermediates Industry to 2028 - Rising Prevalence of Chronic and Infectious Diseases is Driving Growth

Dublin, Aug. 30, 2021 (GLOBE NEWSWIRE) -- The "Pharmaceutical Intermediates Market Forecast to 2028 - COVID-19 Impact and Global Analysis by Type; Applications; Distribution Channel, and Geography" report has been added to ResearchAndMarkets.com's offering.

The global pharmaceutical intermediates market is expected to reach US$ 37,290.33 million in 2028 from US$ 27,356.70 million in 2020. The market is estimated to grow with a CAGR of 3.95% during 2020-2028. Countries in Asia Pacific are emerging as attractive outsourcing locations for pharmaceuticals and biopharmaceuticals industries. Low manufacturing and operating costs in China and India are key factors driving the pharmaceutical manufacturing business in the region. Recent growth in the pharmaceutical industry in both these countries indicate a positive outlook for the pharmaceutical intermediates market. As per the India Brand Equity Foundation (IBEF), an initiative of the Ministry of Commerce & Industry of the Government of India, the value of the pharmaceutical industry in India is expected to reach US$ 100 billion by 2025. Moreover, pharmaceuticals export from India was worth US$ 16.3 billion in 2020; these exports include drug formulations, bulk drugs, intermediates, biologicals, and herbal products.

Flourishing domestic pharmaceutical market in APAC and increasing number of pipeline drugs are further opening new avenues for the contract manufacturers as well as generic drug manufacturing in the region. As per IBEF, India's domestic pharmaceutical market business revenue reached US$ 20.03 billion (INR 1.4 lakh crore) in 2019, with a year-on-year (y-o-y) increase of 9.8% from US$ 18.12 billion (INR 129,015 crore) in 2018. Additionally, to meet the growing demand, many contract-based organizations are expanding their manufacturing capabilities, further boosting the growth of the market. For instance, in January 2020, STA Pharmaceutical Co., Ltd., a subsidiary of WuXi AppTec, opened a new large-scale oligonucleotide API manufacturing facility in China. Thus, the emerging markets hold high potential and huge revenue generation opportunities for the pharmaceutical continuous manufacturing companies.

The pharmaceutical intermediates market, by type, is segmented into GMP, and non GMP. The GMP segment held the largest share of the market in 2020, whereas the same segment is anticipated to register the highest CAGR of 4.4% in the market during the forecast period.

In terms of application, the pharmaceutical intermediates market is segmented antibiotics, antipyretic analgesics, vitamins, and others. The antibiotics segment held the largest share of the market in 2020, also, this segment is anticipated to register the highest CAGR of 4.9% in the market during the forecast period.

The pharmaceutical intermediates market, by distribution channel, is segmented into distributor, and direct sales. The direct sales segment held the largest share of the market in 2020, and distributor segment is estimated to register the highest CAGR of 4.2% in the market during the forecast period.

Reasons to Buy

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the pharmaceutical intermediates market.

  • Highlights key business priorities in order to assist companies to realign their business strategies.

  • The key findings and recommendations highlight crucial progressive industry trends in the global pharmaceutical intermediates market, thereby allowing players across the value chain to develop effective long-term strategies.

  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution

Key Topics Covered:

1. Introduction

2. Pharmaceutical Intermediates Market- Key Takeaways

3. Research Methodology

4. Pharmaceutical Intermediates Market- Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America PEST Analysis
4.2.2 Europe PEST Analysis
4.2.3 APAC PEST Analysis
4.2.4 MEA PEST Analysis
4.2.5 SCAM PEST Analysis
4.3 Expert Opinion

5. Pharmaceutical Intermediates Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Rising Prevalence of Chronic Diseases and Infectious Diseases
5.1.2 Escalating R&D Investments by Pharmaceutical Companies
5.2 Market Restraints
5.2.1 High Cost of Manufacturing
5.3 Market Opportunities
5.3.1 Emerging Markets
5.4 Future Trends
5.4.1 Increasing Adoption of AI-based Tools for Drug Discovery
5.5 Impact Analysis

6. Pharmaceutical Intermediates Market- Global Analysis
6.1 Global Pharmaceutical Intermediates Market Revenue Forecast and Analysis
6.2 Global Pharmaceutical Intermediates Market, By Geography - Forecast and Analysis
6.3 Market Positioning of Key Players

7. Pharmaceutical Intermediates Market Analysis - By Type
7.1 Overview
7.2 Pharmaceutical Intermediates Market Revenue Share, by Type (2020 and 2028)
7.3 GMP
7.3.1 Overview
7.3.2 GMP: Pharmaceutical Intermediates Market- Revenue and Forecast to 2028 (US$ Million)
7.4 Non GMP
7.4.1 Overview
7.4.2 Non GMP: Pharmaceutical Intermediates Market- Revenue and Forecast to 2028 (US$ Million)

8. Pharmaceutical Intermediates Market Analysis - By Application
8.1 Overview
8.2 Pharmaceutical Intermediates Market Revenue Share, by Application (2020 and 2028)
8.3 Antibiotics
8.3.1 Overview
8.3.2 Antibiotics: Pharmaceutical Intermediates Market- Revenue and Forecast to 2028 (US$ Million)
8.4 Antipyretic Analgesics
8.4.1 Overview
8.4.2 Antipyretic Analgesics: Pharmaceutical Intermediates Market- Revenue and Forecast to 2028 (US$ Million)
8.5 Vitamins
8.5.1 Overview
8.5.2 Vitamins: Pharmaceutical Intermediates Market- Revenue and Forecast to 2028 (US$ Million)
8.6 Other
8.6.1 Overview
8.6.2 Other: Pharmaceutical Intermediates Market- Revenue and Forecast to 2028 (US$ Million)

9. Pharmaceutical Intermediates Market- By Distribution Channel
9.1 Overview
9.2 Pharmaceutical Intermediates Market, by Distribution Channel, 2020 and 2028 (%)
9.3 Distributor
9.3.1 Overview
9.3.2 Distributor: Pharmaceutical Intermediates Market- Revenue and Forecast to 2028 (US$ Million)
9.4 Direct Sales
9.4.1 Overview
9.4.2 Direct Sales: Pharmaceutical Intermediates Market- Revenue and Forecast to 2028 (US$ Million)

10. Pharmaceutical Intermediates Market - Geographical Analysis

11. Impact of COVID-19 Pandemic on Global Pharmaceutical Intermediates Market
11.1 North America: Impact Assessment of COVID-19 Pandemic
11.2 Europe: Impact Assessment Of COVID-19 Pandemic
11.3 Asia Pacific: Impact Assessment of COVID-19 Pandemic
11.4 Middle East and Africa: Impact Assessment of COVID-19 Pandemic
11.5 South and Central America: Impact Assessment of COVID-19 Pandemic

12. Pharmaceutical Intermediates Market- Industry Landscape
12.1 Overview
12.2 Growth Strategies Done by the Companies in the Market, (%)
12.3 Organic Developments
12.3.1 Overview
12.4 Inorganic Developments
12.4.1 Overview

13. Company Profiles
13.1 Pfizer Inc.
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Sanofi
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 BASF SE
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Lianhe Chemical Technology Co., Ltd.
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Dishman Carbogen Amcis Ltd
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Codexis
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Midas Pharma GmbH
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 chiracon GmbH
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Dextra Laboratories Limited
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Vertellus Holdings LLC
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments

14. Appendix

For more information about this report visit https://www.researchandmarkets.com/r/b4vall

ADVERTISEMENT
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900